We are live on
!
Find out more
Aviva Portfolio holdings
AUM
$59.6B
1-Year Est. Return
28.44%
This Fund
S&P 500
This Quarter
Est. Return
-16.32%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$13.7B
AUM Growth
-$2.86B
(-17%)
Cap. Flow
+$440M
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
22.94%
Holding
1,002
New
61
Increased
439
Reduced
407
Closed
72
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Trane Technologies
TT
|
+$74.6M |
| 2 |
Comcast
CMCSA
|
+$31.4M |
| 3 |
Charter Communications
CHTR
|
+$29.5M |
| 4 |
HEICO Corp
HEI
|
+$28.9M |
| 5 |
Linde
LIN
|
+$28.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TechnipFMC
FTI
|
+$117M |
| 2 |
Qiagen
QGEN
|
+$82.8M |
| 3 |
Danaher
DHR
|
+$52.2M |
| 4 |
Becton Dickinson
BDX
|
+$31.3M |
| 5 |
ON Semiconductor
ON
|
+$26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.08% |
| 2 | Healthcare | 14.67% |
| 3 | Financials | 14.36% |
| 4 | Consumer Discretionary | 11.05% |
| 5 | Communication Services | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
National Healthcare
NHC
$3.46B
| $3.55M | 0.03% |
+49,500
| New | +$3.92M |
|
602
Pegasystems
PEGA
$5.43B
| $3.54M | 0.03% |
99,518
+50,960
| +105% | +$2.14M |
|
603
Allogene Therapeutics
ALLO
$725M
| $3.54M | 0.03% |
182,090
+113,180
| +164% | +$2.7M |
|
604
Alarm.com
ALRM
$2.79B
| $3.54M | 0.03% |
90,932
+46,373
| +104% | +$2.02M |
|
605
Chegg
CHGG
$94.8M
| $3.54M | 0.03% |
98,807
+47,111
| +91% | +$1.84M |
|
606
Haemonetics
HAE
$3.94B
| $3.53M | 0.03% |
35,401
+19,648
| +125% | +$2.13M |
|
607
Universal Display
OLED
$4.16B
| $3.51M | 0.03% |
+26,664
| New | +$4.59M |
|
608
Paycom
PAYC
$9.62B
| $3.51M | 0.03% |
17,355
+159
| +0.9% | +$43.6K |
|
609
Neurocrine Biosciences
NBIX
$16.8B
| $3.49M | 0.03% |
40,343
+23,615
| +141% | +$2.31M |
|
610
W.P. Carey
WPC
$16.1B
| $3.49M | 0.03% |
61,373
+286
| +0.5% | +$21.7K |
|
|
RAVN
611
DELISTED
Raven Industries Inc
RAVN
| $3.49M | 0.03% |
164,366
+109,665
| +200% | +$3.21M |
|
612
Guidewire Software
GWRE
$14.4B
| $3.48M | 0.03% |
43,921
+28,041
| +177% | +$2.93M |
|
|
NBIS
613
Nebius Group N.V.
NBIS
$46.7B
| $3.48M | 0.03% |
102,274
+254
| +0.2% | +$10.5K |
|
|
614
Qiagen
QGEN
$9.04B
| $3.47M | 0.03% |
81,174
-2,120,303
| -96% | -$82.8M |
|
615
Madrigal Pharmaceuticals
MDGL
$11.9B
| $3.46M | 0.03% |
51,872
+32,721
| +171% | +$2.73M |
|
616
Insulet
PODD
$9.91B
| $3.46M | 0.03% |
+20,893
| New | +$3.82M |
|
617
Regency Centers
REG
$13.9B
| $3.46M | 0.03% |
90,102
+6,164
| +7% | +$355K |
|
|
YMAB
618
DELISTED
Y-mAbs Therapeutics
YMAB
| $3.46M | 0.03% |
+132,613
| New | +$3.85M |
|
619
Tandem Diabetes Care
TNDM
$1.59B
| $3.46M | 0.03% |
+53,731
| New | +$3.76M |
|
620
GoDaddy
GDDY
$11.6B
| $3.46M | 0.03% |
60,513
-1,021
| -2% | -$67.6K |
|
|
SMAR
621
DELISTED
Smartsheet Inc.
SMAR
| $3.45M | 0.03% |
+83,098
| New | +$3.77M |
|
622
Freeport-McMoran
FCX
$98.7B
| $3.44M | 0.03% |
509,479
+467
| +0.1% | +$4.89K |
|
623
Cognex
CGNX
$10.8B
| $3.43M | 0.03% |
81,144
+43,412
| +115% | +$2.17M |
|
624
Royal Gold
RGLD
$19.8B
| $3.42M | 0.03% |
38,977
+23,153
| +146% | +$2.39M |
|
625
Ulta Beauty
ULTA
$23.6B
| $3.42M | 0.03% |
19,462
-246
| -1% | -$61.3K |
|
Similar funds
QCM
NAMI
Aviva's Q1 2020 Portfolio in Review
As of Q1 2020, Aviva held 1,002 positions worth $13.7B, down 17% from $16.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Aviva deployed $440M of net new capital in Q1 2020, opening 61 new positions and adding to 439 existing holdings. Its largest new stake was CubeSmart: 380,714 shares worth $10.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was TechnipFMC, an estimated $117M trimmed.
- Aviva's largest Q1 2020 buy was CubeSmart: 380,714 shares worth $10.2M.
- Aviva added most to Trane Technologies in Q1 2020, an estimated $74.6M increase.
- Aviva's biggest Q1 2020 reduction was TechnipFMC, cutting an estimated $117M.
- Aviva fully exited ON Semiconductor in Q1 2020, selling an estimated $26M.
- Aviva's ten largest holdings make up 23% of its $13.7B portfolio in Q1 2020.
- Aviva opened 61 new positions and closed 72 in Q1 2020.
- Aviva's portfolio value fell 17% quarter-over-quarter to $13.7B.
Based on Aviva's 13F filing for Q1 2020, filed 14 May 2020.